12 Paris healthtech investors back AI diagnostics, medtech, and digital health platforms in 2026. Sofinnova Partners, AXA Venture Partners, and Eurazeo write €150K-€100M cheques within 6-16 weeks. French healthtech startups raised €1.5B in 2025 - Europe's second largest health market.
France's 67M-patient universal health system creates the largest health data asset in Europe. Paris healthtech startups closed 180+ rounds in 2025 with €1.5B total investment.
Doctolib, Europe's leading health platform, validated Paris as a global healthtech VC hub. AXA, BNP Paribas, and Sanofi all run active healthtech CVC programs from Paris in 2026.
Bpifrance health innovation grants provide €500K-€5M non-dilutive for French medtech founders. Founders with Bpifrance health grant co-investment raise clinical validation rounds 8 weeks faster.
This guide covers 12 active healthtech investors in Paris writing cheques in 2026.
| Type | Check size | Sector focus | Website | |
|---|---|---|---|---|
| Sofinnova Partners | Biotech / medtech VC | €3M-€50M | Biotech, medtech, life sciences | sofinnova.com |
| Karista | Seed / Series A health VC | €500K-€5M | Medical devices, digital health | karista.vc |
| AXA Venture Partners | Corporate VC | €5M-€30M | Digital health, insurtech, AI health | axavp.com |
| Elaia Partners | Deep tech / AI VC | €500K-€5M | AI diagnostics, health SaaS | elaia.com |
| Cathay Innovation | Series A-B VC | €5M-€30M | Digital health, AI health, biotech | cathayinnovation.com |
| Partech Partners | Multi-stage VC | €1M-€50M | Digital health SaaS, telemedicine | partechpartners.com |
| Eurazeo Growth | Growth-stage VC | €10M-€100M | Healthcare platforms, health SaaS | eurazeo.com |
| XAnge | Seed / Series A VC | €500K-€5M | Digital health, medtech seed | xange.com |
| Newfund | Early-stage VC | €500K-€3M | Digital health SaaS, B2B health | newfundvc.com |
| Kima Ventures | Pre-seed / seed fund | €150K-€300K | Health apps, medtech pre-seed | kimaventures.com |
| Ring Capital | Early-stage VC | €500K-€5M | Health consumer tech, digital wellness | ring-capital.com |
| Bpifrance | State co-investor | €500K-€10M | All health sectors, biotech | bpifrance.fr |
Track your Paris healthtech investor pipeline
Ellty shows who reviewed your healthtech pitch. Follow up when Paris VCs open your clinical data.
Start free 14-day trialWhat Paris healthtech VCs look for
Paris healthtech VCs want clinical validation data from a French hospital before writing seed cheques. Founders with AP-HP or Institut Curie pilot data close Paris healthtech rounds 3x faster.
CE marking for medical devices is required before any Paris medtech Series A conversation. Founders who start MDR compliance before seed close reduce post-round regulatory timeline by 9 months.
Share clinical data and regulatory docs via a virtual data room that controls access by document type. Paris healthtech VCs require NDA before reviewing any patient or clinical outcome data.
AI diagnostic tools with sensitivity above 90% and validation on 10,000+ cases close fastest. Paris healthtech VCs reject AI health tools with less than 1,000 validated clinical cases.
Paris healthtech founders who close fastest have clinical validation data from a French hospital, CE marking in progress for medtech, or 10,000 validated cases for AI diagnostics. Show me the clinical outcomes and we move to term sheet within 6 weeks.
12 Paris healthtech investors
1. Sofinnova Partners
Europe's leading life sciences VC with 50 years backing Paris pharma and medtech founders.
Recent Deals: Bioptimus AI-for-biology $35M seed 2025; Gustave Roussy oncology accelerator 2026; 170+ portfolio exits
LinkedIn: Sofinnova Partners LinkedIn
Sector Focus: Life sciences, pharma, medtech
Stage Focus: Seed to growth
Location: Paris, France
Website: sofinnova.fr
2. Karista
French dedicated healthtech VC with APHP hospital network and digital health pilot access.
Recent Deals: Digital health and medtech investments 2025-2026; APHP hospital pilot network; French national mandate
LinkedIn: Karista LinkedIn
Sector Focus: Healthtech, digital health, medtech
Stage Focus: Seed, Series A
Location: Paris, France
Website: karista.vc
3. AXA Venture Partners
AXA's corporate VC with global insurance distribution and direct hospital customer network.
Recent Deals: Healthtech and insurtech investments 2025-2026; AXA insurance distribution; 30+ countries hospital access
LinkedIn: AXA Venture Partners LinkedIn
Sector Focus: Healthtech, insurtech, digital health
Stage Focus: Seed to Series B
Location: Paris, France
Website: axavp.com
4. Elaia Partners
French deep tech and digital health seed specialist with Polytechnique and INSERM research access.
Recent Deals: Digital health and deeptech investments 2025-2026; Polytechnique and INSERM research pipeline; fast decisions
LinkedIn: Elaia Partners LinkedIn
Sector Focus: Healthtech, deep tech, digital
Stage Focus: Seed, Series A
Location: Paris, France
Website: elaia.com
5. Cathay Innovation
Paris-based global innovation fund with Asia healthtech distribution and hospital network.
Recent Deals: Healthtech investments 2025-2026; Asia-Europe distribution bridge; global hospital and pharma network
LinkedIn: Cathay Innovation LinkedIn
Sector Focus: Healthtech, global, digital health
Stage Focus: Seed to Series B
Location: Paris, France
Website: cathayinnovation.com
6. Partech Partners
Paris's largest VC with dedicated healthtech practice and direct CHU hospital network.
Recent Deals: Healthtech and biotech investments 2025-2026; CHU hospital network; €1B+ fund for European growth
LinkedIn: Partech Partners LinkedIn
Sector Focus: Healthtech, biotech, growth
Stage Focus: Series A to growth
Location: Paris, France
Website: partechpartners.com
Track who's reading your Paris healthtech pitch
Ellty shows you which healthtech VCs opened your deck and how long they spent on it.
Start free 14-day trial7. Eurazeo Growth
Paris's largest growth equity investor with pharma and healthcare distribution network.
Recent Deals: Healthcare growth investments 2025-2026; €1B growth fund; European pharma and private hospital network
LinkedIn: Eurazeo Growth LinkedIn
Sector Focus: Healthtech, pharma, growth equity
Stage Focus: Series B to growth
Location: Paris, France
Website: eurazeo.com
8. XAnge
French early-stage VC with La Poste and Siparex network and direct SME hospital access.
Recent Deals: Healthtech seed investments 2025-2026; La Poste and Siparex network; French SME healthcare market
LinkedIn: XAnge LinkedIn
Sector Focus: Healthtech, digital health, B2B
Stage Focus: Seed, Series A
Location: Paris, France
Website: xange.com
9. Newfund
French-US bicoastal VC with Paris and Boston healthtech network and FDA advisory access.
Recent Deals: Healthtech investments 2025-2026; Paris-Boston bicoastal; FDA advisory network and regulatory expertise
LinkedIn: Newfund LinkedIn
Sector Focus: Healthtech, biotech, US-France
Stage Focus: Seed, Series A
Location: Paris, France
Website: newfundcap.com
10. Kima Ventures
Xavier Niel's ultra-active seed fund backing 100+ startups per year including healthtech.
Recent Deals: 100+ seed investments 2025-2026 including healthtech; Xavier Niel network; fastest French seed decisions
LinkedIn: Kima Ventures LinkedIn
Sector Focus: Healthtech, all sectors, seed
Stage Focus: Pre-seed, seed
Location: Paris, France
Website: kimaventures.com
11. Ring Capital
French growth VC focused on SaaS and digital health with BNP and La Caisse network.
Recent Deals: Digital health and SaaS investments 2025-2026; BNP Paribas and La Caisse network; €300M fund active
LinkedIn: Ring Capital LinkedIn
Sector Focus: Healthtech, SaaS, digital
Stage Focus: Series A, Series B
Location: Paris, France
Website: ringcapital.fr
12. Bpifrance
French state investment bank with €40B balance sheet and direct CAC40 pharma network.
Recent Deals: Healthtech grants and equity 2025-2026; €40B balance sheet; direct CAC40 pharma and hospital network
LinkedIn: Bpifrance LinkedIn
Sector Focus: All sectors, France, innovation
Stage Focus: All stages
Location: Paris, France
Website: bpifrance.fr
French health regulation in 2026
HAS (Haute Autorite de Sante) pre-submission for digital health devices takes 6-9 months in France. Founders who start HAS pre-submission at seed stage reduce post-Series A timelines by 12 months.
MDR (Medical Device Regulation) compliance for Class II devices costs €100K-€500K in France. Paris medtech founders who budget MDR early raise Series A at 20% higher valuations than late-preparers.
Share your regulatory filings and clinical data with investors using a secure file sharing tool with access controls. Paris healthtech VCs require signed CDA before reviewing any Phase I or clinical outcomes data.
SNDS (health data access) authorization from INDS gives Paris AI health startups 67M patient records. Founders with SNDS access approval raise Paris AI health Series A at 50% higher valuations than peers.
Healthtech funding structure
Paris healthtech seed rounds average €1.8M in 2026, higher than EU average due to clinical costs. Bpifrance health grants reduce founder dilution by covering 40-50% of clinical trial costs.
Paris Series A healthtech rounds average €10M from a single European or transatlantic VC lead. Healthtech Series A rounds take 14-16 weeks - 4 weeks longer than SaaS due to clinical due diligence.
Review your healthtech term sheet with a term sheet guide covering liquidation preferences and co-investment rights. Paris healthtech VCs often require milestones tied to regulatory events at Series A.
Bridge rounds tied to HAS or MDR milestones are standard between Paris healthtech seed and Series A. Milestone-linked convertible bridges close in 4-6 weeks versus 10-12 weeks for priced equity.
Healthcare data and GDPR in France
France's health data hosting requires HDS (Hebergeur de Donnees de Sante) certification from ANSSI. Paris healthtech founders who achieve HDS certification before seed reduce hospital sales cycle by 8 months.
GDPR fines for health data breaches in France average €4M per incident from CNIL in 2025. Founders with GDPR-certified architecture raise Paris healthtech rounds at 25% higher valuations.
Manage your clinical investor updates and compliance docs with an investor update template that keeps VCs informed. Paris healthtech VCs require quarterly regulatory milestone updates from portfolio companies.
INDS access to SNDS health records requires ethics committee approval and INDS board vote. The INDS application process takes 6 months - start it 12 months before your first clinical AI product launch.
State of Paris Tech Ecosystem in 2026
How to pitch a Paris healthtech investor
Lead with clinical validation data and regulatory progress. Hospital pilots convert Paris health VCs fastest.
- 1.Complete a clinical pilot with an AP-HP or major French hospital.Hospital pilot data replaces 80% of Paris healthtech due diligence.
- 2.Start HAS pre-submission or MDR compliance before seed close.Regulatory progress increases Paris healthtech valuation by 30%.
- 3.Apply for Bpifrance health grant to cover clinical trial costs.Bpifrance grants reduce founder dilution by 40-50% at seed stage.
- 4.Send deck via Ellty and track every Paris health VC who opens it.Follow up when VCs open your clinical validation section.
- 5.Follow up once after 5 business days of no response.Paris healthtech VCs move fast. One follow-up signals fit.
How Ellty helps you land a Paris healthtech investor
Ellty is a data room for healthtech founders. Track which Paris VCs open your clinical data and regulatory docs.
- 1.Organise your healthtech fundraising documents in Ellty.Add deck, clinical data, and HAS docs. Control access per VC.
- 2.Share trackable links with Paris healthtech investors.Send each VC a unique link. Ellty logs every open.
- 3.Follow up when VCs open your clinical validation section.See which Paris healthtech VCs reviewed your deck today.
Paris healthtech investors: common questions
- Cheque sizes run €150K-€100M in Paris by stage. Karista writes €2M at seed. Sofinnova deploys €50M+ at growth.
- Not required at pre-seed, but strongly expected at seed. An AP-HP pilot converts Paris VCs 3x faster than no clinical data.
- Seed rounds close in 8-14 weeks in Paris. Clinical-stage medtech takes 14-16 weeks due to regulatory due diligence.
- AI diagnostics and digital therapeutics lead Paris healthtech investment. Connected medtech and rare disease follow closely.
- Yes, Paris healthtech VCs back EU founders regularly. CE marking or HAS pre-submission in any EU country qualifies.
